期刊文献+

腺苷A2AR拮抗剂对中枢炎症性小胶质细胞形态和功能的影响

Effects of adenosine A2A receptor antagonist on lipopolysaccharide induced inflammatory BV-2 microglial cells’ morphology and function
下载PDF
导出
摘要 目的:探讨腺苷A2A受体拮抗剂对实验性自身免疫性脑脊髓炎(EAE)的治疗作用及其对中枢炎症性小胶质细胞形态和功能的影响。方法:MOG35-55免疫诱导建立EAE模型,EAE小鼠出现神经功能缺损症状后开始腹腔注射腺苷A2AR拮抗剂至发病后第10天。ELISA法检测中枢神经系统内IFN-γ、IL-17、TGF-β、IL-10的表达情况,免疫荧光双重染色法检测小胶质细胞内M1型细胞标志物诱导型一氧化氮合酶(iNOS)和M2型细胞标志物精氨酸酶I(ArgI)的合成情况。离体培养BV-2小胶质细胞,LPS诱导的小胶质细胞炎症反应,并予A2AR拮抗剂干预,Real-time PCR和ELISA法检测M1型和M2型细胞相关的细胞因子RNA表达水平和分泌水平。Western Blot法检测各组小胶质细胞内M1型和M2型细胞标志物的表达量。结果:腺苷A2AR拮抗剂能有效缓解发病后EAE小鼠的神经功能缺损症状,降低IFN-γ的分泌水平,使M1型细胞相关的iNOS合成减少,M2型细胞相关的ArgI合成增多。腺苷A2AR拮抗剂能减少LPS刺激后BV-2小胶质细胞M1型细胞相关的细胞因子IL-1β的mRNA表达量和分泌量,对M2型细胞相关的细胞因子及蛋白无显著影响。结论:腺苷A2AR拮抗剂对发病后的EAE小鼠有肯定的治疗作用,其机制可能与改变中枢炎症过程中小胶质细胞的表型(M1/M2转换)改变(形态和功能)有关。 AIM:To investigate the therapeutic effects of adenosine A2A receptor antagonist on experimental autoimmune encephalomyelitis(EAE)and to explore the regulating effects on microglia morphology and function.METHODS:EAE model was induced by MOG35-55 in C57BL/6 mice.Adenosine A2AR antagonists were given by intraperitoneal injection as EAE mice showed neurobehavioral deficits.The treatment lasted ten days until EAE mice reached highest clinical score.ELISA method was used to detect the expression of pro-inflammatory cytokine in central nervous system;immunofluorescence double staining was used to detect M1 cell related markers and M2 cell related markers in microglia.In vitro,activated BV-2 microglia cell line was induced by lipopolysaccharide(LPS)and then was intervened by the A2AR antagonists.Real-time PCR and ELISA method were used to detect the M1 and M2 cells related cytokines.Western Blot method was used to detect the synthesis of M1 and M2 cell related markers.RESULTS:Adenosine A2AR antagonists can effectively ameliorate the EAE-induced neurobehavioral deficits when treated after onset of EAE,and can reduce the secretion of pro-inflammatory cytokine IFN-γ,and M1 cells related iNOS synthesis while increased M2 type cells related ArgI synthesis.Adenosine A2AR antagonists can reduce LPS-induced BV-2 M1 microglial cells related cytokines IL-1β,and had no influence on M2 cells related cytokines and protein.CONCLUSION:Adenosine A2AR antagonists have definite therapeutic effect on EAE mice when treated after the onset of EAE;its underlying mechanism may be involved with shift of phenotype(M1/M2)and changes in morphology and function of microglia during neuro-inflammatory process.
作者 陈瑜 殷为勇 陈艳艳 朱振国 郑荣远 郑浏璞 CHEN Yu;YIN Weiyong;CHEN Yanyan;ZHU Zhenguo;ZHENG Rongyuan;ZHENG Liupu(Department of Rehabilitation,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,Zhejiang,China;Department of Neurology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,Zhejiang,China;Department of Anesthesiology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,Zhejiang,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2019年第12期1376-1384,共9页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 温州市科技局项目(Y20180740) 国家自然科学基金项目(81371321)
关键词 腺苷A2A受体 实验性自身免疫性脑脊髓炎 小胶质细胞 受体拮抗剂 adenosine A2A receptor experimental autoimmune encephalomyelitis microglia antagonist
  • 相关文献

参考文献1

二级参考文献27

  • 1吕广明,吴辉群,栗卓,刘苏,韩笑,季达峰.大鼠皮质脊髓束Luxol Fast Blue染色[J].南通大学学报(医学版),2008,28(1):5-6. 被引量:9
  • 2Garrington TP,Johnson GL.Organization and regulation of mitogen-activated protein kinase signaling pathways[J].Curr Opin Cell Biol,1999,11:211-218.
  • 3Widmann C,Gibson S,Jarpe MB,et al.Mitogen-activated protein kinase:conservation of a three-kinase module from yeast to human[J].Physiol Rev,1999,79:143-180.
  • 4Bonvin C,Guillon A,van Bemmelen MX,et al.Role of the amino-terminal domains of MEKKs in the activation of NF kappa B and MAPK pathways and in the regulation of cell proliferation and apoptosis[J].Cell Signal,2002,14:123-131.
  • 5Johnson GL,Lapadat R.Mitogen-activated protein kinase pathways mediated by ERK,JNK,and p38 protein kinases[J].Science,2002,298:1911-1912.
  • 6Xia Z,Dickens M,Raingeaud J,et al.Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis[J].Science,1995,270:1326-1331.
  • 7Kaminska B.MAPK signalling pathways as molecular targets for antiinflammatory therapy-from molecular mechanisms to therapeutic benefits[J].Biochim Biophy Acta,2005,1754:253-262.
  • 8Weaver A,Goncalves da Silva A,Nuttall RK,et al.An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization[J].FASEB,2005,19:1668-1670.
  • 9Melani A,Gianfriddo M,Vannucchi MG,et al.The selective A2A receptor antagonist SCH 58261 protects from neurological deficit,brain damage and activation of p38 MAPK in rat focal cerebral ischemia[J].Brain Res,2006,1073-1074:470-480.
  • 10Melani A,Cipriani S,Vannucchi MG,et al.Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia[J].Brain,2009,132:1480-1495.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部